Viewing Study NCT06631404



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06631404
Status: RECRUITING
Last Update Posted: None
First Post: 2024-10-07

Brief Title: Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
Sponsor: None
Organization: None

Study Overview

Official Title: Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
Status: RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Systemic Lupus Erthymatosous SLE is achronic inflammatory multi system auto immue disease characterized by pathogenic auto anti bodies production against nuclear structures Bolouri et al2022 SLE affecting mainly woemn of childbearing age and is chracterized by unpredictable flares and remissions disease variety varied from mild episode disorder to arpidly progressive life -threatening illness

LN is diagnosed by either the presence of proteinuria 05gday active urinary sediment or an unexplained rise in serum creatinine there fore identifying new invasive biomarkers of LN severity and outcome is mandatory Renal Arterial resistive index RRI is anon invasive biomarker that has been studied as apotential indicator of disease activity in LN patients
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None